Jazz Pharmaceuticals (JAZZ) Current Taxes (2012 - 2026)

Jazz Pharmaceuticals' Current Taxes history runs 15 years deep, the most recent figure standing at $93.7 million for Q1 2026.

• On a quarterly basis, Current Taxes rose 195.01% year-over-year to $93.7 million in Q1 2026; TTM through Mar 2026 was $93.7 million, a 195.01% increase from a year earlier, with the FY2025 full-year figure at $56.3 million, up 200.15% from the prior year.
• Current Taxes rose to $93.7 million in Q1 2026 per JAZZ's latest filing, from $56.3 million in the prior quarter.
• Across five years, Current Taxes topped out at $93.7 million in Q1 2026 and bottomed at $5.8 million in Q2 2022.
• The 5-year median for Current Taxes is $49.3 million (2024), against an average of $47.6 million.
• Across the five-year window, Current Taxes tumbled 69.51% in 2022 and surged 1065.1% in 2023, its largest moves.
• Year by year, Current Taxes stood at $7.7 million in 2022, then jumped by 354.5% to $35.1 million in 2023, then plunged by 46.52% to $18.8 million in 2024, then soared by 200.15% to $56.3 million in 2025, then soared by 66.43% to $93.7 million in 2026.
• Per Business Quant, the three latest JAZZ Current Taxes figures stand at $93.7 million (Q1 2026), $56.3 million (Q4 2025), and $91.1 million (Q3 2025).